750469AA6
Radius Health Inc
Could not find a ticker for this position, may be a filing error
A biopharmaceutical company focused on bone health, best known for TYMLOS, a once-daily injection that builds new bone in people with osteoporosis at high risk of fracture. Founded in 2003, it was taken private in 2022 by investment firms. Its name nods to the radius, the forearm bone often studied in bone-density research.
CONVERTIBLEUnderlying: RDUSCUSIP: 750469AA6HealthcareUS1 derivative reporter
3% Convertible Notes due 2024